Undiscovered Gems in India for October 2024
In This Article:
In the last week, the Indian market has stayed flat but it is up 40% over the past year with earnings forecast to grow by 17% annually. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can uncover undiscovered gems that align well with these promising conditions.
Top 10 Undiscovered Gems With Strong Fundamentals In India
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| 3B Blackbio Dx | 0.38% | -0.88% | -1.47% | ★★★★★★ |
| Kokuyo Camlin | 27.11% | 23.20% | 75.70% | ★★★★★★ |
| Knowledge Marine & Engineering Works | 35.48% | 42.61% | 42.95% | ★★★★★★ |
| TechNVision Ventures | 100.73% | 20.37% | 68.50% | ★★★★★★ |
| Gallantt Ispat | 18.85% | 37.56% | 37.26% | ★★★★★☆ |
| Voith Paper Fabrics India | 0.07% | 10.95% | 9.70% | ★★★★★☆ |
| Master Trust | 37.05% | 27.64% | 41.99% | ★★★★★☆ |
| Indo Tech Transformers | 2.30% | 22.05% | 60.31% | ★★★★★☆ |
| Avantel | 5.92% | 33.97% | 37.33% | ★★★★★☆ |
| Share India Securities | 24.23% | 37.59% | 48.98% | ★★★★☆☆ |
Here's a peek at a few of the choices from the screener.
Akums Drugs and Pharmaceuticals
Simply Wall St Value Rating: ★★★★★☆
Overview: Akums Drugs and Pharmaceuticals Limited is engaged in the manufacturing and sale of pharmaceutical products and active pharmaceutical ingredients both in India and internationally, with a market cap of ?143.83 billion.
Operations: Akums generates revenue primarily from its CDMO segment, contributing ?36.32 billion, followed by branded and generic formulations at ?6.76 billion, and APIs at ?3.03 billion.
Akums Drugs and Pharmaceuticals, a vibrant player in the Indian market, recently turned profitable with a net income of ?601.71 million for Q1 2024, contrasting a previous loss of ?1.88 billion. Its net debt to equity ratio stands at 40%, deemed satisfactory, while interest payments are well-covered by EBIT at 9.7 times coverage. The company has secured exclusive rights to develop and market Triple Hair Inc's products in India, signaling strategic expansion efforts within the pharmaceutical sector.
IFB Industries
Simply Wall St Value Rating: ★★★★★☆
Overview: IFB Industries Limited, along with its subsidiaries, is engaged in the manufacturing and trading of home appliances both in India and globally, with a market capitalization of ?92.43 billion.
Operations: IFB Industries generates revenue primarily from its Home Appliances segment, contributing ?36.32 billion, followed by Engineering at ?8.55 billion. The Steel and Motor segments add ?1.65 billion and ?670 million respectively to the total revenue streams.